Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide tablets for weight loss are not currently available on the NHS. The oral formulation, branded Wegovy tablets, received MHRA approval on 11 June 2026 as the UK's first licensed oral GLP-1 medicine for weight management — but a NICE appraisal is required before NHS commissioning can follow, and none has begun. For now, access means a private prescription following clinical assessment. That reality shapes every decision covered below, and it's worth understanding clearly before you decide what to do next. These are prescription-only medicines; a qualified prescriber determines whether they are clinically appropriate for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The MHRA granted approval for Wegovy tablets on 11 June 2026, making the UK the first country in Europe to license an oral GLP-1 medicine for weight management. That is significant. What it does not do is trigger NHS prescribing automatically. In England, a medicine joins the NHS formulary for a specific condition only after NICE issues a positive technology appraisal, and that process typically takes twelve months or more from marketing authorisation. The MHRA and NICE are separate organisations with separate remits; one decides whether a medicine is safe and effective enough to be sold in the UK, the other decides whether the NHS should fund it and for whom.
There is a common misconception that MHRA approval effectively means it is available everywhere. It does not. Wegovy injections, for instance, hold a NICE recommendation under TA875 but access through NHS specialist services still involves long waiting lists for most people. Tablets are earlier in that journey still. This is not a gap in the system so much as the system working exactly as designed, and understanding it prevents a frustrating wait for something that is not yet coming.
Scotland, Wales and Northern Ireland operate their own appraisal bodies, so timing and criteria may differ across the nations. If you are researching this from outside England, it is worth checking with your health board directly.
MHRA approval does matter practically. It means that a registered UK prescriber can legally issue a private prescription for Wegovy tablets today, and that a GPhC-registered pharmacy can legally dispense it. The clinical standards are identical to any other licensed medicine: a prescriber must assess you, satisfy themselves that the treatment is appropriate, and issue a formal prescription. There are no shortcuts built into the approval.
The licensed population is adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related condition such as high blood pressure, raised cholesterol, type 2 diabetes, prediabetes or obstructive sleep apnoea. Lower thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone is never the whole picture; your prescriber looks at your medical history, any current medicines, and contraindications before deciding.
The dosing schedule starts at 1.5mg and moves through 4mg and 9mg to the 25mg maintenance dose, with at least a month at each level. People already established on the 2.4mg weekly injection may move directly to the 25mg tablet, subject to their prescriber's assessment. For exact administration guidance (including the 30-minute fasting window and the small sip of plain water required) the patient information leaflet is the definitive reference, as described in the NHS semaglutide medicines page.
Because there is no NHS route, your decision is really about which private prescriber and pharmacy to trust. The starting point is always the GPhC register: any online pharmacy dispensing this medicine should be verifiable there. You can check our own GPhC registration (premises number 9012878) at the pharmacy register.
At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not an automated system. If you are clinically suitable and order before noon on a weekday, treatment is dispatched the same day and arrives via tracked DPD delivery the next working day. There is no subscription and no auto-renewal; every repeat order goes through clinical review again. You can read more about how oral semaglutide works if you want a fuller picture of the medicine before deciding.
If you are curious about the cost side of things, our treatment overview explains what is included in the price. The one thing worth saying here: patients who want to buy semaglutide tablets online should know that for a prescription medicine, the cheapest option is rarely the safest test to apply. Supply chain legitimacy and clinical oversight are what actually protect you.
Wegovy tablets are not suitable during pregnancy, breastfeeding, or if you are trying to conceive. They are not licensed for under-18s. If any of those apply, your prescriber will discuss what that means for you. Questions about whether a specific medicine or existing condition changes your eligibility are best raised directly with our clinical team via our contact page or during your consultation.
NICE appraisals move at their own pace. If you are waiting to see whether semaglutide tablets eventually become available on the NHS, that is a completely reasonable position, and checking the NICE website for any published appraisal consultations costs nothing. For those wondering where they can buy semaglutide tablets in the UK right now, private treatment through a regulated prescriber is the legal alternative.
Our FAQs page covers some of the questions that come up most often about eligibility and the consultation process, including guidance for anyone looking to buy a semaglutide tablet for the first time. If you have already decided you want to explore this properly, the next step is a free consultation with our prescribers. There is no obligation to proceed, and you get a genuine clinical review either way. You can also learn more about who we are before you start.
When you are ready, patients can view semaglutide tablets for sale and buy semaglutide tablets by starting your free consultation, and our prescribers will take it from there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.